CanBas Co., Ltd. (4575.T)
JPY 1013.0
(1.3%)
JPY 1013.0
(1.3%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -984 Million JPY | -46.65% |
| 2022 | -671 Million JPY | -10.36% |
| 2021 | -608 Million JPY | -89.38% |
| 2020 | -321.05 Million JPY | 3.3% |
| 2019 | -332 Million JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q4 | -644 Thousand JPY | -550.51% |
| 2023 Q1 | -120 Thousand JPY | 25.0% |
| 2023 FY | - JPY | 100.0% |
| 2023 Q3 | -99 Thousand JPY | 18.18% |
| 2023 Q2 | -121 Thousand JPY | -0.83% |
| 2022 Q2 | -175 Thousand JPY | 30.28% |
| 2022 FY | -671 Million JPY | -10.36% |
| 2022 Q4 | -160 Thousand JPY | -88.24% |
| 2022 Q3 | -85 Thousand JPY | 51.43% |
| 2022 Q1 | -251 Thousand JPY | 0.0% |
| 2021 FY | -608 Million JPY | -89.38% |
| 2020 FY | -321.05 Million JPY | 3.3% |
| 2019 FY | -332 Million JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 1.88 Billion JPY | 152.304% |
| PRISM BioLab Co.,LTD | 80.3 Million JPY | 1325.313% |
| GNI Group Ltd. | 22.43 Billion JPY | 104.387% |
| Linical Co., Ltd. | 3.77 Billion JPY | 126.044% |
| Trans Genic Inc. | 2.24 Billion JPY | 143.748% |
| MEDINET Co., Ltd. | 98.25 Million JPY | 1101.506% |
| Soiken Holdings Inc. | 2.48 Billion JPY | 139.639% |
| Cytori Cell Research Institute, Inc. | 1.29 Billion JPY | 176.125% |
| AnGes, Inc. | -3.06 Billion JPY | 67.899% |
| OncoTherapy Science, Inc. | -177.71 Million JPY | -453.686% |
| Nxera Pharma Co., Ltd. | 9.66 Billion JPY | 110.182% |
| Immuno-Biological Laboratories Co., Ltd. | 517.29 Million JPY | 290.221% |
| NanoCarrier Co., Ltd. | 110.95 Million JPY | 986.838% |
| Carna Biosciences, Inc. | 1.45 Billion JPY | 167.834% |
| D. Western Therapeutics Institute, Inc. | 391.69 Million JPY | 351.214% |
| RaQualia Pharma Inc. | 1.65 Billion JPY | 159.415% |
| Chiome Bioscience Inc. | 398.59 Million JPY | 346.867% |
| Kidswell Bio Corporation | 1.03 Billion JPY | 194.672% |
| PeptiDream Inc. | 17.21 Billion JPY | 105.715% |
| Oncolys BioPharma Inc. | 30.6 Million JPY | 3315.161% |
| Ribomic Inc. | -10.5 Million JPY | -9269.644% |
| SanBio Company Limited | -14.5 Million JPY | -6684.335% |
| Healios K.K. | 108 Million JPY | 1011.111% |
| BrightPath Biotherapeutics Co., Ltd. | -341 Thousand JPY | -288463.05% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -59.04 Million JPY | -1566.497% |
| Delta-Fly Pharma, Inc. | -1.51 Million JPY | -64979.365% |
| StemRIM | -44.34 Million JPY | -2118.765% |
| CellSource Co., Ltd. | 3.18 Billion JPY | 130.895% |
| FunPep Company Limited | -680.28 Million JPY | -44.645% |
| Kringle Pharma, Inc. | 69.25 Million JPY | 1520.939% |
| Stella Pharma Corporation | 217.29 Million JPY | 552.834% |
| TMS Co., Ltd. | -6.95 Million JPY | -14058.273% |
| Noile-Immune Biotech Inc. | 314.56 Million JPY | 412.817% |
| Cuorips Inc. | 9.63 Million JPY | 10317.008% |
| K Pharma,Inc. | 910 Million JPY | 208.132% |
| Takara Bio Inc. | 25.45 Billion JPY | 103.865% |
| ReproCELL Incorporated | 1.1 Billion JPY | 189.072% |
| PhoenixBio Co., Ltd. | 1.19 Billion JPY | 182.339% |
| StemCell Institute Inc. | 1.57 Billion JPY | 162.441% |
| Japan Tissue Engineering Co., Ltd. | 1.66 Billion JPY | 159.036% |
| CellSeed Inc. | 107.15 Million JPY | 1018.296% |